BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 16696641)

  • 21. Detection of IgM and IgG antibodies to Cryptococcus neoformans proteins in blood donors and HIV patients with active cryptococcosis.
    Chai HC; Tay ST
    Mycoses; 2009 Mar; 52(2):166-70. PubMed ID: 18643920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A chronological history of the International Conference on Cryptococcus and Cryptococcosis (ICCC), an invaluable forum for growth of the cryptococcal research field and clinical practice.
    Kwon-Chung KJ; Perfect JR; Levitz SM
    Mycopathologia; 2012 Jun; 173(5-6):287-93. PubMed ID: 22038679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molluscum or a mimic?
    de Souza JA
    Am J Med; 2006 Nov; 119(11):927-9. PubMed ID: 17071157
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cryptococcosis in AIDS patients: case study from 1996 to 2006 in Paroissien Hospital].
    Mónaco LS; Tamayo Antabak N
    Rev Argent Microbiol; 2008; 40(4):218-21. PubMed ID: 19213244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genotype and mating type analysis of Cryptococcus neoformans and Cryptococcus gattii isolates from China that mainly originated from non-HIV-infected patients.
    Feng X; Yao Z; Ren D; Liao W; Wu J
    FEMS Yeast Res; 2008 Sep; 8(6):930-8. PubMed ID: 18671745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current scenario of cryptococcosis and antifungal susceptibility pattern in India: a cause for reappraisal.
    Capoor MR; Mandal P; Deb M; Aggarwal P; Banerjee U
    Mycoses; 2008 May; 51(3):258-65. PubMed ID: 18399907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ophthalmic manifestations of immune reconstitution inflammatory syndrome associated with Cryptococcus neoformans.
    Khurana RN; Javaheri M; Rao N
    Ocul Immunol Inflamm; 2008; 16(4):185-90. PubMed ID: 18716955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New ITS genotype of Cryptococcus gattii isolated from an AIDS patient in Brazil.
    Kang Y; Tanaka H; Moretti ML; Mikami Y
    Microbiol Immunol; 2009 Feb; 53(2):112-6. PubMed ID: 19291095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy.
    Lortholary O; Poizat G; Zeller V; Neuville S; Boibieux A; Alvarez M; Dellamonica P; Botterel F; Dromer F; Chêne G
    AIDS; 2006 Nov; 20(17):2183-91. PubMed ID: 17086058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation of Cryptococcus adeliensis from clinical samples and the environment in Germany.
    Tintelnot K; Losert H
    J Clin Microbiol; 2005 Feb; 43(2):1007. PubMed ID: 15695732
    [No Abstract]   [Full Text] [Related]  

  • 31. [Efficiency of ethanol of Thonningia sanguinea against Cryptococcus neoformans].
    Ouattara B; Kra AM; Coulibaly A; Guede-Guina F
    Sante; 2007; 17(4):219-22. PubMed ID: 18299265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population-based surveillance for cryptococcosis in an antiretroviral-naive South African province with a high HIV seroprevalence.
    McCarthy KM; Morgan J; Wannemuehler KA; Mirza SA; Gould SM; Mhlongo N; Moeng P; Maloba BR; Crewe-Brown HH; Brandt ME; Hajjeh RA
    AIDS; 2006 Nov; 20(17):2199-206. PubMed ID: 17086060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Susceptibility of clinical isolates of Cryptococcus neoformans to amphotericin B using time-kill methodology.
    Pappalardo MC; Szeszs MW; Martins MA; Baceti LB; Bonfietti LX; Purisco SU; Baez AA; Melhem MS
    Diagn Microbiol Infect Dis; 2009 Jun; 64(2):146-51. PubMed ID: 19345042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cryptococcal peritonitis as the first AIDS-defining illness in Zimbabwe.
    Ferrand RA; Maunganidze AJ; Mgodi NM
    Trop Doct; 2006 Oct; 36(4):249-50. PubMed ID: 17034711
    [No Abstract]   [Full Text] [Related]  

  • 35. Management of cryptococcosis: how are we doing?
    Perfect JR
    PLoS Med; 2007 Feb; 4(2):e47. PubMed ID: 17284156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combating increased antifungal drug resistance in
    Deng H; Song J; Huang Y; Yang C; Zang X; Zhou Y; Li H; Dai B; Xue X
    Acta Biochim Biophys Sin (Shanghai); 2023 Feb; 55(4):540-547. PubMed ID: 36815374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The sixth international conference on cryptococcus and cryptococcosis.
    Coenjaerts FE
    FEMS Yeast Res; 2006 Mar; 6(2):312-7. PubMed ID: 16487353
    [No Abstract]   [Full Text] [Related]  

  • 38. AIDS-associated central nervous system cryptococcosis: a Brazilian case study.
    Pappalardo MC; Paschoal RC; Melhem MS
    AIDS; 2007 Sep; 21(14):1971-2. PubMed ID: 17721106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of proton nuclear magnetic resonance spectroscopy to the study of Cryptococcus and cryptococcosis.
    Sorrell TC; Wright LC; Malik R; Himmelreich U
    FEMS Yeast Res; 2006 Jun; 6(4):558-66. PubMed ID: 16696651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cryptococcus: from environmental saprophyte to global pathogen.
    May RC; Stone NR; Wiesner DL; Bicanic T; Nielsen K
    Nat Rev Microbiol; 2016 Feb; 14(2):106-17. PubMed ID: 26685750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.